Intelerad CEO Jordan Bazinsky outlines how advanced technology and strategic partnerships can help medical imaging withstand financial, regulatory, and workforce pressures.
Key Details
- 1Medicare radiology reimbursement declined 3.4% in 2024 and 2.83% in 2025, part of a 25% decrease since 2005.
- 2FDA staff reductions may delay imaging device and AI tool approvals, affecting innovation availability.
- 3Radiologist workforce shortage persists; ARRT exam takers fell 18% between 2006 and 2022, with demand for CT and MRI rising 3-5% yearly.
- 4AI, integrated platforms, telehealth, and compliance tools are recommended to improve efficiency, care coordination, and regulatory adherence.
- 5Collaborations with vendors and academic institutions can mitigate outsourcing and strengthen the radiologist pipeline.
Why It Matters

Source
AuntMinnie
Related News

Women's Uncertainty About AI in Breast Imaging May Limit Acceptance
Many women remain unclear about the role of AI in breast imaging, creating hesitation toward its adoption.

Stanford Team Introduces Real-Time AI Safety Monitoring for Radiology
Stanford researchers introduced an ensemble monitoring model to provide real-time confidence assessments for FDA-cleared radiology AI tools.

Harrison.ai Receives FDA Breakthrough Status for Imaging AI Device
Harrison.ai has been awarded three FDA breakthrough device designations for its imaging AI solutions, including a tool for obstructive hydrocephalus triage.